லியோ கையகப்படுத்துதல் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

   Assumes a Consolidation ratio for the Common Shares of 1.6667:1
In the event that the Qualifying Transaction is completed, the directors of the Company who are not directors of the Resulting Issuer will have a period of 12 months to exercise their Options.
In addition, the Company will also apply to the TSXV to extend the expiry date of the option grants expiring on February 17, 2021 to March 5, 2023.
The Options are expected to represent less than 1% of the issued and outstanding shares of the resulting issuer following the Qualifying Transaction.
In addition, the Supplement will add an additional approval threshold for the Continuance Resolution (as defined in the Circular) asking shareholders to approve, among other things, the reclassification of the Corporation s existing Common Shares as subordinate voting shares (the ....

United States , United Kingdom , Gerry Goldberg , Company Common , Psybio Therapeutics Inc , Leo Acquisitions Corp , Capital Pool Company , Regulation Services Provider , Venture Exchange , Psybio Therapeutics , Combination Agreement , Qualifying Transaction , British Columbia , Common Share , Common Shares , Resulting Issuer , Continuance Resolution , Multiple Voting Shares , Subordinate Voting Share , Multiple Voting Share , Subordinate Voting Shares , Minority Approval , Multiple Voting , Business Corporations Act , Capital Pool Companies , Corporate Finance Manual ,